Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Cumberland Pharmaceuticals Inc. (CPIX) had Stock-Based Compensation of $0.15M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$10.84M |
|
$-0.74M |
|
$2.01M |
|
$8.83M |
|
$11.58M |
|
$-0.75M |
|
$0.02M |
|
$-0.73M |
|
$-0.73M |
|
$-0.74M |
|
$-0.74M |
|
$-0.74M |
|
$-0.74M |
|
$-0.75M |
|
$0.29M |
|
14.96M |
|
14.96M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$31.21M |
|
$0.30M |
|
$36.70M |
|
$67.91M |
|
$23.97M |
|
$5.24M |
|
$16.26M |
|
$40.23M |
|
$27.68M |
|
$10.78M |
|
$27.68M |
|
14.96M |
|
| Cash Flow Statement Financials | |
$4.74M |
|
$-0.94M |
|
$-5.68M |
|
$17.96M |
|
$16.09M |
|
$-1.88M |
|
|
Stock-Based Compensation |
$0.15M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.30 |
|
-- |
|
-- |
|
0.16 |
|
0.19 |
|
81.44% |
|
-6.90% |
|
-6.90% |
|
-- |
|
-6.73% |
|
-6.84% |
|
$4.67M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.62 |
|
1.05 |
|
85.68 |
|
-2.66% |
|
-6.82% |
|
-1.08% |
|
-2.23% |
|
$1.85 |
|
$0.31 |
|
$0.32 |
|